Document Preview Unavailable

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants

Chi, Xiaojing; Zhang, Xinhui; Pan, Shengnan; Yu, Yanying; Lin, Tianli; et al.  bioRxiv, Dec 25, 2021.

You might have access to this document